retatrutide pen peptide (LY3437943) Injector | Triple Agonist Research Retatrutide Pen 10mg | High-Purity

GLP-1 drug usage was associated with a reduced risk of just about everything bad: substance use and psychotic disorders, seizures, neuro-cognitive disorders (including Alzheimers disease and dementia), coagulation disorders [e.g., means clotting], cardio-metabolic disorders, infectious illnesses and several respiratory conditions. When I initially read this study in January, it seemed too good to be true

doi:10.1093/ajcn/69.6.1135 Birkeland E, Gharagozlian S, Gulseth HL, Birkeland KI, Hartmann B, Holst JJ, et al

SH2B1 defends against energy imbalance, obesity, and metabolic disease via a paraventricular hypothalamusdorsal raphe nucleus neurocircuit

Regulatory restrictions may apply